Ohan Manoukian

Q: What is Ohan S Manoukian email address?

Email Ohan S Manoukian at ohan.manoukian@merckgroup.com. This email is the most updated Ohan S Manoukian's email found in 2026.

Q: How to contact Ohan S Manoukian?

To contact Ohan S Manoukian send an email to ohan.manoukian@merckgroup.com. (updated on March 25, 2024)

Director, Asset Commercial Lead, Oncology at Moderna | Greater Boston

About Ohan Manoukian

As the Director, Asset Commercial Lead for the Global Oncology Franchise at Moderna, Ohan S Manoukian plays a pivotal role in shaping the commercial landscape for cutting-edge cancer therapies. Currently, he is at the forefront of driving the commercial strategy and launch readiness for mRNA-4157, an Individualized Neoantigen Therapy (INT) that represents a significant advancement in personalized medicine. This innovative therapy, developed in partnership with Merck & Co, leverages the power of mRNA technology to create tailored cancer treatments that are designed to stimulate the immune system to target and destroy tumor cells effectively.

Ohan's expertise in global oncology business development and strategic leadership is instrumental in navigating the complexities of the oncology market. His prior experience as Chief of Staff and in management consulting has equipped him with a unique blend of skills, including project management, marketing strategy, and statistical analysis, all of which are critical in ensuring the successful commercialization of mRNA-4157. His ability to adapt and learn quickly in a rapidly evolving industry underscores his commitment to innovation and excellence.

In addition to his strategic responsibilities, Ohan is deeply involved in cross-functional collaboration, working closely with research and development teams to align clinical insights with market needs. His focus on launch readiness encompasses not only the development of robust marketing strategies but also the integration of patient-centric approaches that enhance the overall treatment experience. With a strong foundation in regenerative medicine and tissue engineering, Ohan is dedicated to advancing the field of oncology, ultimately aiming to improve patient outcomes through transformative therapies.

Ohan Manoukian Work